Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001737287-24-000056
Filing Date
2024-08-07
Accepted
2024-08-07 16:06:17
Documents
75
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q allo-20240630.htm   iXBRL 10-Q 1485896
2 EX-10.1 allo-20240630xex101.htm EX-10.1 258254
3 EX-10.2 allo-20240630xex102.htm EX-10.2 308113
4 EX-10.3 allo-20240630xex103.htm EX-10.3 74354
5 EX-10.4 allo-20240630xex104.htm EX-10.4 519568
6 EX-10.6 allo-20240630xex106.htm EX-10.6 33027
7 EX-10.7 allo-20240630xex107.htm EX-10.7 13604
8 EX-31.1 allo-20240630xex311.htm EX-31.1 9784
9 EX-31.2 allo-20240630xex312.htm EX-31.2 9734
10 EX-32.1 allo-20240630xex321.htm EX-32.1 6994
  Complete submission text file 0001737287-24-000056.txt   8643364

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT allo-20240630.xsd EX-101.SCH 61968
12 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT allo-20240630_cal.xml EX-101.CAL 53331
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT allo-20240630_def.xml EX-101.DEF 402042
14 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT allo-20240630_lab.xml EX-101.LAB 648987
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT allo-20240630_pre.xml EX-101.PRE 503434
77 EXTRACTED XBRL INSTANCE DOCUMENT allo-20240630_htm.xml XML 791136
Mailing Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 457-2700
Allogene Therapeutics, Inc. (Filer) CIK: 0001737287 (see all company filings)

EIN.: 823562771 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38693 | Film No.: 241183633
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)